Deep Learning for High-Order Drug-Drug Interaction Prediction
- 4 September 2019
- conference paper
- conference paper
- Published by Association for Computing Machinery (ACM) in Proceedings of the 10th ACM International Conference on Bioinformatics, Computational Biology and Health Informatics
Abstract
Drug-drug interactions (DDIs) and their associated adverse drug reactions (ADRs) represent a significant detriment to the public health. Existing research on DDIs is primarily focused on pairwise DDI detection and prediction. It is highly needed to develop effective computational tools for high-order DDI prediction. Here we show that deep learning can be effectively utilized to predict ADRs induced from high-order DDIs. In this manuscript, we present a deep learning model D3I for cardinality-invariant and order-invariant high-order DDI prediction. The D3I models achieve 0.740 F1 value and 0.847 AUC value on balanced high-order DDI prediction, and outperform other models on order-2 DDI prediction. These results demonstrate the strong potential of D3I and deep learning models in tackling the prediction problems of high-order DDIs and their induced ADRs. In addition, D3I is able to derive single drug representations, which conform to our current knowledge on single drugs, from their behaviors in drug combinations. D3I can also correctly predict ADRs for drug combinations in which no single drugs on their own induce ADRs, and improve ADR prediction on drug pairs by learning from all drug combinations. To the best of our knowledge, D3I is the first deep model for high-order DDI prediction.Keywords
Funding Information
- National Science Foundation (IIS-1827472, IIS-1855501)
This publication has 24 references indexed in Scilit:
- Mining clinical text for signals of adverse drug-drug interactionsJournal of the American Medical Informatics Association, 2014
- Systematic Prediction of Pharmacodynamic Drug-Drug Interactions through Protein-Protein-Interaction NetworkPLoS Computational Biology, 2013
- Informatics confronts drug–drug interactionsTrends in Pharmacological Sciences, 2013
- Combinatorial drug therapy for cancer in the post-genomic eraNature Biotechnology, 2012
- Novel Data-Mining Methodologies for Adverse Drug Event Discovery and AnalysisClinical Pharmacology & Therapeutics, 2012
- Individualized risk for statin-induced myopathy: current knowledge, emerging challenges and potential solutionsPharmacogenomics, 2012
- INDI: a computational framework for inferring drug interactions and their associated recommendationsMolecular Systems Biology, 2012
- Prediction of Drug Combinations by Integrating Molecular and Pharmacological DataPLoS Computational Biology, 2011
- Detecting Drug Interactions From Adverse-Event Reports: Interaction Between Paroxetine and Pravastatin Increases Blood Glucose LevelsClinical Pharmacology & Therapeutics, 2011
- Application of in silico approaches to predicting drug–drug interactionsJournal of Pharmacological and Toxicological Methods, 2001